| Hazard Information | Back Directory | [Uses]
DGKα-IN-6 is a DGKα inhibitor with the IC50 of 1.377 nM, extracted from patent WO2022271650 (compound 143). DGKα-IN-6 has the potential for cancer study. | [References]
[1] Codelli, Julian A., Preparation of substituted imidazoquinazolines and pyridotriazolopyrimidines as diacylglycerol kinase modulators. WO2022271650 |
|
|